• PDF: Delivered by email usually within 12 to 24 UK business hours.

Canada Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

Canada Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Canada Endoscopy Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Endoscopy Devices in Canada

Scope

  • The report provides endoscopy devices information broken down into detailed categories and segments in Canada.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the endoscopy devices market in Canada.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 Table Of Contents
  • 1 Table Of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Endoscopy Devices
        • 2.2.1.1 Flexible Endoscope
        • 2.2.1.2 Rigid Endoscope
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Sector Review
    • 3.2 Healthcare Expenditure
    • 3.3 Healthcare Infrastructure
  • 4 Endoscopy Devices in Canada
    • 4.1 Endoscopy Devices Overall Revenues (2000-2012)
    • 4.2 Endoscopy Devices Overall Volume (2000-2012)
    • 4.3 Endoscopy Devices Overall Company Share (2006-2007)
  • 5 Flexible Endoscope in Canada
    • 5.1 Flexible Endoscope Overall Revenue (2000-2012)
    • 5.2 Flexible Endoscope Overall Volume (2000-2012)
    • 5.3 Flexible Endoscope Average Price (2000-2012)
    • 5.4 Flexible Endoscope Distribution Share (2006-2007)
    • 5.5 Flexible Endoscope Company Share (2006-2007)
  • 6 Rigid Endoscope in Canada
    • 6.1 Rigid Endoscope Overall Revenues (2000-2012)
    • 6.2 Rigid Endoscope Overall Volume (2000-2012)
    • 6.3 Rigid Endoscope Average Price (2000-2012)
    • 6.4 Rigid Endoscope Distribution Share (2006-2007)
    • 6.5 Rigid Endoscope Company Share (2006-2007
  • 7 OLYMPUS CORPORATION Company Profile
    • 7.1 Company Overview
    • 7.2 Business Overview
      • 7.2.1 Imaging Systems Business
        • 7.2.1.1 Overview
        • 7.2.1.2 Financials
        • 7.2.1.3 Capital Expenditure
        • 7.2.1.4 Market View
        • 7.2.1.5 Key Strategies
      • 7.2.2 Information and Communication Business
        • 7.2.2.1 Overview
        • 7.2.2.2 Financials
        • 7.2.2.3 Capital Expenditure
        • 7.2.2.4 Key Strategies
      • 7.2.3 Life Sciences Business
        • 7.2.3.1 Overview
        • 7.2.3.2 Financials
        • 7.2.3.3 Capital Expenditure
        • 7.2.3.4 Market View
        • 7.2.3.5 Key Strategies
      • 7.2.4 Medical Systems Business
        • 7.2.4.1 Overview
        • 7.2.4.2 Financials
        • 7.2.4.3 Capital Expenditure
        • 7.2.4.4 Market View
        • 7.2.4.5 Key Strategies
      • 7.2.5 Others
        • 7.2.5.1 Overview
        • 7.2.5.2 Financials
        • 7.2.5.3 Capital Expenditure
        • 7.2.5.4 Market View
        • 7.2.5.5 Key Strategies
      • 7.2.6 Major Products and Services
      • 7.2.7 History
    • 7.3 Value Chain Analysis
      • 7.3.1 Manufacturing
        • 7.3.1.1 In House Manufacturing
      • 7.3.2 Product Development
        • 7.3.2.1 Regulatory Approvals
        • 7.3.2.2 Research and Development
      • 7.3.3 Sales and Marketing
        • 7.3.3.1 Partnerships and Alliances
        • 7.3.3.2 Licensing Agreements
        • 7.3.3.3 E-distribution
    • 7.4 SWOT Analysis
      • 7.4.1 OLYMPUS CORPORATION Strengths
        • 7.4.1.1 Expansion of business activities
        • 7.4.1.2 Strong internal control system
        • 7.4.1.3 Strong financial performance
      • 7.4.2 OLYMPUS CORPORATION Weaknesses
        • 7.4.2.1 Sluggish growth in Imaging Systems Business division
        • 7.4.2.2 Weak presence in Asia
        • 7.4.2.3 Inconsistent profit margin
      • 7.4.3 OLYMPUS CORPORATION Opportunities
        • 7.4.3.1 Focused R&D
        • 7.4.3.2 Launching of new products
        • 7.4.3.3 Expansion of global markets
      • 7.4.4 OLYMPUS CORPORATION Threats
        • 7.4.4.1 Price competition
        • 7.4.4.2 Dependent on key suppliers
        • 7.4.4.3 Pricing pressures in Japan
    • 7.5 Revenue Analysis
      • 7.5.1 Revenue by Segment
      • 7.5.2 Revenue by Geography
    • 7.6 Financial and Operational Review
      • 7.6.1 Financial Statements
      • 7.6.2 Financial Ratios
      • 7.6.3 Share Holding Structure
    • 7.7 Locations And Subsidiaries
    • 7.8 Financial Deals Landscape
      • 7.8.1 Spiration Secures $18.5 Million In Series G Round Of Financing
      • 7.8.2 Terumo Forms Joint Venture With Olympus Corporation
      • 7.8.3 Olympus Signs An Agreement With Visen Medical
      • 7.8.4 Olympus Acquires Stake In Cytori Therapeutics
      • 7.8.5 Olympus Corporation Forms A Joint Venture With Movaz Networks
      • 7.8.6 Spiration Secures $13.4 Million In Series F Financing
      • 7.8.7 Olympus Corporation Forms Partnership With Takano
      • 7.8.8 Olympus To Acquire Gyrus Group
    • 7.9 Recent Developments
      • 7.9.1 Apr 01, 2008: Olympus Appoints New CEO
      • 7.9.2 Feb 04, 2008: Olympus Reports Q3 Fiscal 2008 Results
      • 7.9.3 Nov 06, 2007: Olympus Reports Q2 Fiscal 2008 Results
      • 7.9.4 Jul 30, 2007: Olympus Reports Q1 Fiscal 2008 Results
      • 7.9.5 Jul 30, 2007: Olympus Reports H1 Fiscal 2006 Results
      • 7.9.6 Jul 30, 2007: Olympus Reports Q1 Fiscal 2006 Results
      • 7.9.7 Jul 30, 2007: Olympus Reports Fiscal 2006 Results
      • 7.9.8 Jul 30, 2007: Olympus Reports Q3 Fiscal 2006 Results
      • 7.9.9 Jul 30, 2007: Olympus Reports Q1 Fiscal 2007 Results
      • 7.9.10 May 08, 2007: Olympus Reports Fiscal 2007 Results
      • 7.9.11 Feb 05, 2007: Olympus Reports Q3 Fiscal 2007 Results
    • 7.10 OLYMPUS CORPORATION Pipeline Products
      • 7.10.1 OLYMPUS CAPSULE ENDOSCOPE SYSTEM
        • 7.10.1.1 Product Overview
        • 7.10.1.2 Product Description
        • 7.10.1.3 Product Status
      • 7.10.2 Single Balloon Enteroscopy (SBE) system
        • 7.10.2.1 Product Overview
        • 7.10.2.2 Product Description
        • 7.10.2.3 Product Status
        • 7.10.2.4 Product Milestone
  • 8 KARL STORZ GmbH & Co. KG Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
      • 8.2.1 Major Products and Services
      • 8.2.2 History
    • 8.3 Locations And Subsidiaries
    • 8.4 Financial Deals Landscape
      • 8.4.1 KARL STORZ Signs An Agreement With EndoGastric Solutions
  • 9 PENTAX Medical Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
      • 9.2.1 Major Products and Services
      • 9.2.2 History
    • 9.3 Locations And Subsidiaries
    • 9.4 Financial Deals Landscape
      • 9.4.1 PENTAX Medical Company Acquires Operating Assets Of KayPENTAX (formerly Kay Elemetrics)
    • 9.5 Recent Developments
      • 9.5.1 Oct 06, 2007: PENTAX Appoints VP, Sales And Marketing
  • 10 B. Braun Melsungen AG Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Aesculap division
        • 10.2.1.1 Overview
        • 10.2.1.2 Financials
        • 10.2.1.3 Market View
        • 10.2.1.4 Key Strategies
      • 10.2.2 B. Braun Avitum division
        • 10.2.2.1 Overview
        • 10.2.2.2 Financials
        • 10.2.2.3 Market View
        • 10.2.2.4 Key Strategies
      • 10.2.3 Hospital Care division
        • 10.2.3.1 Overview
        • 10.2.3.2 Financials
        • 10.2.3.3 Key Strategies
      • 10.2.4 Out Patient Market (OPM) division
        • 10.2.4.1 Overview
        • 10.2.4.2 Financials
        • 10.2.4.3 Market View
        • 10.2.4.4 Key Strategies
      • 10.2.5 Major Products and Services
      • 10.2.6 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
        • 10.3.1.1 In House Manufacturing
        • 10.3.1.2 Outsourcing
      • 10.3.2 Product Development
        • 10.3.2.1 Regulatory Approvals
        • 10.3.2.2 Clinical Trials
        • 10.3.2.3 Research and Development
      • 10.3.3 Sales and Marketing
        • 10.3.3.1 Partnerships and Alliances
        • 10.3.3.2 Licensing Agreements
    • 10.4 SWOT Analysis
      • 10.4.1 B. Braun Melsungen AG Strengths
        • 10.4.1.1 L.I.F.E certification
        • 10.4.1.2 Significant revenues
        • 10.4.1.3 Worldwide existence
      • 10.4.2 B. Braun Melsungen AG Weaknesses
        • 10.4.2.1 High SG&A expenses
        • 10.4.2.2 FDA warning letter
      • 10.4.3 B. Braun Melsungen AG Opportunities
        • 10.4.3.1 Acquisitions
        • 10.4.3.2 Expansion of business
        • 10.4.3.3 Broad product portfolio
      • 10.4.4 B. Braun Melsungen AG Threats
        • 10.4.4.1 Foreign exchange
        • 10.4.4.2 Intense competition and change in technologies
    • 10.5 Revenue Analysis
      • 10.5.1 Revenue by Segment
      • 10.5.2 Revenue by Geography
    • 10.6 Financial and Operational Review
      • 10.6.1 Financial Statements
      • 10.6.2 Financial Ratios
    • 10.7 Locations And Subsidiaries
    • 10.8 Financial Deals Landscape
      • 10.8.1 B. Braun Signs An Agreement With Nipro
      • 10.8.2 B. Braun Enters Into A Licensing Agreement With Chartie Hospital
      • 10.8.3 B. Braun Signs An Agreement With Charite
    • 10.9 Recent Developments
      • 10.9.1 Mar 26, 2008: B. Braun Reports 2007 Results
      • 10.9.2 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO
      • 10.9.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics
      • 10.9.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results
      • 10.9.5 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico
      • 10.9.6 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production
      • 10.9.7 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou
    • 10.10 B. Braun Melsungen AG Pipeline Products
      • 10.10.1 Coroflex Please
        • 10.10.1.1 Product Overview
        • 10.10.1.2 Product Description
        • 10.10.1.3 Product Status
        • 10.10.1.4 Product Milestone
      • 10.10.2 SeQuent Please
        • 10.10.2.1 Product Overview
        • 10.10.2.2 Product Description
        • 10.10.2.3 Product Status
  • 11 Fujinon Corporation Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Major Products and Services
      • 11.2.2 History
    • 11.3 Locations And Subsidiaries
    • 11.4 Financial Deals Landscape
      • 11.4.1 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration
    • 11.5 Recent Developments
      • 11.5.1 Jul 11, 2006: Fujinon Reports Fiscal 2007 Results
  • 12 Regulation System
    • 12.1 Medical Equipment Approval Process
      • 12.1.1 Classification
      • 12.1.2 Conformity Assessment
        • 12.1.2.1 Class II
        • 12.1.2.2 Class III
        • 12.1.2.3 Class IV
      • 12.1.3 License Fee
      • 12.1.4 License Application Processing Duration
    • 12.2 Labeling and Packaging
    • 12.3 Post-Market Surveillance
  • 13 Pricing and Reimbursement
    • 13.1 Canada Medical Equipment Pricing and Reimbursement
  • 14 Distribution Structure
    • 14.1 Canada Medical Equipment Distribution Structure
  • 15 APPENDIX
    • 15.1 Global Markets Direct Research Methodology
    • 15.2 Coverage
    • 15.3 Secondary Research
    • 15.4 Primary Research
    • 15.5 Models
    • 15.6 Forecasts
    • 15.7 Expert Panels
    • 15.8 Currency Conversion
    • 15.9 Contact Us
    • 15.10 Disclaimer
  • LIST OF TABLES
  • List of Tables
    • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
    • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
    • Table 3: Doctors by Specialty in Canada, 2003-2007
    • Table 4: Endoscopy Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Table 5: Endoscopy Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 6: Endoscopy Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 7: Endoscopy Devices, Canada, Category Revenues ($ mn), 2000-2012
    • Table 8: Endoscopy Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
    • Table 9: Endoscopy Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 10: Endoscopy Devices, Canada, Category Volume (Units), 2000-2012
    • Table 11: Endoscopy Devices, Canada, Category Volume (Units), Historic, 2000-2007
    • Table 12: Endoscopy Devices, Canada, Category Volume (Units), Forecast, 2007-2012
    • Table 13: Endoscopy Devices, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 14: Flexible Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 15: Flexible Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 16: Flexible Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
    • Table 17: Flexible Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Table 18: Flexible Endoscope, Canada, Average Price ($), Historic, 2000-2007
    • Table 19: Flexible Endoscope, Canada, Average Price ($), Forecast, 2007-2012
    • Table 20: Flexible Endoscope, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 21: Flexible Endoscope, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 22: Rigid Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 23: Rigid Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 24: Rigid Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
    • Table 25: Rigid Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Table 26: Rigid Endoscope, Canada, Average Price ($), Historic, 2000-2007
    • Table 27: Rigid Endoscope, Canada, Average Price ($), Forecast, 2007-2012
    • Table 28: Rigid Endoscope, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 29: Rigid Endoscope, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 30: OLYMPUS CORPORATION, SWOT Analysis, 2007
    • Table 31: OLYMPUS CORPORATION, Revenue by Segment, Yen Million, 2003-2007
    • Table 32: OLYMPUS CORPORATION, Revenue by Geography, Yen Million, 2003-2007
    • Table 33: OLYMPUS CORPORATION, Financial Statements, Yen Million, 2003-2007
    • Table 34: OLYMPUS CORPORATION, Financial Ratios, Yen Million, 2003-2007
    • Table 35: OLYMPUS CORPORATION, Share Holding Structure
    • Table 36: OLYMPUS CORPORATION, Other Locations
    • Table 37: OLYMPUS CORPORATION, Other Locations(Contd..)
    • Table 38: OLYMPUS CORPORATION, Subsidiaries
    • Table 39: KARL STORZ GmbH & Co. KG, Other Locations
    • Table 40: KARL STORZ GmbH & Co. KG, Other Locations(Contd..)
    • Table 41: PENTAX Medical Company, Other Locations
    • Table 42: B. Braun Melsungen AG, SWOT Analysis, 2006
    • Table 43: B. Braun Melsungen AG, Revenue by Segment, Euro Thousand, 2002-2006
    • Table 44: B. Braun Melsungen AG, Revenue by Geography, Euro Thousand, 2002-2006
    • Table 45: B. Braun Melsungen AG, Financial Statements, Euro Thousand, 2002-2006
    • Table 46: B. Braun Melsungen AG, Financial Ratios, Euro Thousand, 2002-2006
    • Table 47: B. Braun Melsungen AG, Subsidiaries
    • Table 48: B. Braun Melsungen AG, Subsidiaries(Contd..)
    • Table 49: Fujinon Corporation, Subsidiaries
    • Table 50: Medical Equipment Classification in Canada, 2007
    • Table 51: Medical Equipment Licensing Fee in Canada, 2007
    • Table 52: Medical Equipment License Processing Duration in Canada, 2007
    • Table 53: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
  • List of Figures
    • Figure 1: Healthcare Financing in Canada, 2004
    • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
    • Figure 3: Endoscopy Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Figure 4: Endoscopy Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: Endoscopy Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: Endoscopy Devices, Canada, Category Revenues ($ mn), 2000-2012
    • Figure 7: Endoscopy Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 8: Endoscopy Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: Endoscopy Devices, Canada, Category Volume (Units), 2000-2012
    • Figure 10: Endoscopy Devices, Canada, Category Volume (Units), Historic, 2000-2007
    • Figure 11: Endoscopy Devices, Canada, Category Volume (Units), Forecast, 2007-2012
    • Figure 12: Endoscopy Devices, Canada, Company Share (%), 2007
    • Figure 13: Flexible Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Flexible Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Flexible Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
    • Figure 16: Flexible Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Figure 17: Flexible Endoscope, Canada, Average Price ($), Historic, 2000-2007
    • Figure 18: Flexible Endoscope, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 19: Flexible Endoscope, Canada, Distribution Share (%), 2007
    • Figure 20: Flexible Endoscope, Canada, Company Share (%), 2007
    • Figure 21: Rigid Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 22: Rigid Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 23: Rigid Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
    • Figure 24: Rigid Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Figure 25: Rigid Endoscope, Canada, Average Price ($), Historic, 2000-2007
    • Figure 26: Rigid Endoscope, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 27: Rigid Endoscope, Canada, Distribution Share (%), 2007
    • Figure 28: Rigid Endoscope, Canada, Company Share (%), 2007
    • Figure 29: OLYMPUS CORPORATION, Value Chain Analysis
    • Figure 30: B. Braun Melsungen AG, Value Chain Analysis
    • Figure 31: Global Markets Direct Methodology
+44 20 8816 8548

Ask a question about Canada Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

Enter the characters you see in the picture below
Captcha